Literature DB >> 7387617

Characterization of the subunit composition of HGPRTase from human erythrocytes and cultured fibroblasts.

V I Zannis, L J Gudas, D W Martin.   

Abstract

Hypoxanthine-guanine phosphoribosyltransferase is a ubiquitous human enzyme, the inherited deficiency of which leads to a specific metabolic-neurological syndrome. Native acrylamide isoelectric focusing revealed that the human enzyme consists of different numbers of isoenzymes depending on the tissue of origin. The erythrocytic enzyme has the most isoenzymes while the enzyme from cultured fibroblasts has only a single isoenzyme. The isoenzyme pattern of the erythrocytic enzyme changes on storage of the crude hemolysate at 4 C. Treatment of the stored crude hemolysate with 4.5 M urea and 0.35 mM beta-mercaptoethanol results in an isoenzyme pattern similar to that of the fresh crude extract. Thus the additional isoenzymes are generated on storage not by covalent modification of the enzyme but probably by binding of small molecules to the enzyme or to association of the enzyme molecules. Hypoxanthine-guanine phosphoribosyltransferase has been purified to 80% homogeneity in three steps, DEAE Sephadex chromatography, heat treatment at 85 C for 5 min, and hydroxylapatite chromatography. Denaturing two-dimensional gel electrophoresis of the erythrocytic enzyme revealed that the erythrocytic enzyme is composed of three major types of subunits (1-3) with the same molecular weight but different isoelectric points. In contrast, the fibroblast enzyme is composed of only a single type of subunit, which comigrates with subunit 1 of the erythrocytic enzyme. Since there is a single genetic locus in humans for HGPRTase (the enzyme is X linked) (Nyhan et al., 1967), the observed subunit modification of the erythrocyte enzyme appears to be the result of posttranslational modification. These findings provide a simple explanation for the observed electrophoretic properties of human HGPRTase. A patient with 0.5% of HGPRTase activity in his erythrocytes was found to have small amounts (greater than 0.5% but less than 5% of normal) of the erythrocytic HGPRTase subunits.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7387617     DOI: 10.1007/bf00504356

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  27 in total

1.  Characterization of mutant subunits of human purine nucleoside phosphorylase.

Authors:  L J Gudas; V I Zannis; S M Clift; A J Ammann; G E Staal; D W Martin
Journal:  J Biol Chem       Date:  1978-12-25       Impact factor: 5.157

2.  Chinese hamster hypoxanthine-guanine phosphoribosyltransferase. Purification, structural, and catalytic properties.

Authors:  A S Olsen; G Milman
Journal:  J Biol Chem       Date:  1974-07-10       Impact factor: 5.157

3.  Purification and characterization of human erythrocyte purine nucleoside phosphorylase and its subunits.

Authors:  V Zannis; D Doyle; D W Martin
Journal:  J Biol Chem       Date:  1978-01-25       Impact factor: 5.157

4.  Assignment of nucleoside phosphorylase to D-14 and localization of X-linked loci in man by somatic cell genetics.

Authors:  F Ricciuti; F H Ruddle
Journal:  Nat New Biol       Date:  1973-02-07

5.  An association between the kinetic and electrophoretic properties of human purine-nucleoside-phosphorylase isozymes.

Authors:  B M Turner; R A Fisher; H Harris
Journal:  Eur J Biochem       Date:  1971-12

6.  Human hypoxanthine phosphoribosyltransferase. I. Purification, properties, and specificity.

Authors:  T A Krenitsky; R Papaioannou; G B Elion
Journal:  J Biol Chem       Date:  1969-03-10       Impact factor: 5.157

7.  Inherited disorder of purine metabolism. Correlation between central nervous system dysfunction and biochemical defects.

Authors:  F M Rosenbloom; W N Kelley; J Miller; J F Henderson; J E Seegmiller
Journal:  JAMA       Date:  1967-10-16       Impact factor: 56.272

8.  Characterization of the subunits of purine nucleoside phosphorylase from cultured normal human fibroblasts.

Authors:  V I Zannis; L J Gudas; D W Martin
Journal:  Biochem Genet       Date:  1979-08       Impact factor: 1.890

9.  Hypoxanthine phosphoribosyltransferase deficiency: association of reduced catalytic activity with reduced levels of immunologically detectable enzyme protein.

Authors:  K S Upchurch; A Leyva; W J Arnold; E W Holmes; W N Kelley
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

10.  Analysis of HeLa cell hypoxanthine phosphoribosyltransferase mutants and revertants by two-dimensional polyacrylamide gel electrophoresis: evidence for silent gene activation.

Authors:  G Milman; E Lee; G S Ghangas; J R McLaughlin; M George
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

View more
  10 in total

1.  Herpes simplex virus-mediated human hypoxanthine-guanine phosphoribosyltransferase gene transfer into neuronal cells.

Authors:  T D Palella; L J Silverman; C T Schroll; F L Homa; M Levine; W N Kelley
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

Review 2.  The Jeremiah Metzger lecture. Current status of human gene therapy.

Authors:  W N Kelley; T D Palella
Journal:  Trans Am Clin Climatol Assoc       Date:  1988

3.  Assignment of genes to the human X chromosome by the two-dimensional electrophoretic analysis of total cell proteins from rodent-human somatic cell hybrids.

Authors:  D R Cox; U Francke; C J Epstein
Journal:  Am J Hum Genet       Date:  1981-07       Impact factor: 11.025

4.  Human hypoxanthine-guanine phosphoribosyltransferase: studies of the normal and five mutant forms of the enzyme.

Authors:  W N Kelley; J M Wilson
Journal:  Trans Am Clin Climatol Assoc       Date:  1983

5.  Molecular basis of hypoxanthine-guanine phosphoribosyltransferase deficiency in ten subjects determined by direct sequencing of amplified transcripts.

Authors:  B L Davidson; S A Tarlé; T D Palella; W N Kelley
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

6.  Human hypoxanthine-guanine phosphoribosyltransferase. Demonstration of structural variants in lymphoblastoid cells derived from patients with a deficiency of the enzyme.

Authors:  J M Wilson; B W Baugher; P M Mattes; P E Daddona; W N Kelley
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

7.  Twenty-seven protein polymorphisms by two-dimensional electrophoresis of serum, erythrocytes, and fibroblasts in two pedigrees.

Authors:  D Goldman; L R Goldin; P Rathnagiri; S J O'Brien; J A Egeland; C R Merril
Journal:  Am J Hum Genet       Date:  1985-09       Impact factor: 11.025

8.  Hypoxanthine-guanine phosphoribosyltransferase in human erythroid cells: properties of the isozymes.

Authors:  G G Johnson; S A Nash
Journal:  Biochem Genet       Date:  1983-04       Impact factor: 1.890

9.  Identification of a single nucleotide change in a mutant gene for hypoxanthine-guanine phosphoribosyltransferase (HPRT Ann Arbor).

Authors:  S Fujimori; Y Hidaka; B L Davidson; T D Palella; W N Kelley
Journal:  Hum Genet       Date:  1988-05       Impact factor: 4.132

10.  Protein variations associated with Lesch-Nyhan syndrome.

Authors:  C R Merril; D Goldman; M Ebert
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.